Literature DB >> 25624311

Mycoplasma pneumoniae detection causes excess antibiotic use in Norwegian general practice: a retrospective case-control study.

Mats Foshaug1, Maria Vandbakk-Rüther2, Dagfinn Skaare3, Nils Grude3, Morten Lindbæk4.   

Abstract

BACKGROUND: The 2011 Mycoplasma pneumoniae epidemic in Norway resulted in many GP consultations and significantly increased the prescription of macrolide antibiotics. AIM: To investigate the signs, symptoms, course, and prescription patterns of antibiotics in patients positive for M. pneumoniae compared with patients negative for M. pneumoniae. DESIGN AND
SETTING: A retrospective case-control study using questionnaires collected from GPs in a county in Norway. A total of 212 M. pneumoniae positive and 202 control patients were included.
METHOD: Descriptive statistics and logistic regression analyses were performed on the reported findings.
RESULTS: Forty-eight per cent of patients positive for M. pneumoniae received an antibiotic at first consultation. Another 45% in the same group received antibiotics after the polymerase chain reaction (PCR) result was known, although these patients were not clinically different from all other patients not receiving an antibiotic at first consultation. Logistic regression analysis to evaluate independent predictors for prescription of antibiotics at first consultation showed that the following factors were significantly associated: elevated C-reactive protein (CRP) level, temperature >38.0°C, pathological findings on pulmonary auscultation, and impaired general condition. Elevated CRP level, younger age, temperature >38.0°C, short duration of symptoms, and absence of rhinitis were found to be positive predictors for M. pneumoniae infection.
CONCLUSION: A positive PCR test for M. pneumoniae tends to trigger an antibiotic prescription, irrespective of the severity of the patient's condition at first consultation. New guidelines for treatment and possibly PCR testing should be established. © British Journal of General Practice 2015.

Entities:  

Keywords:  Mycoplasma pneumoniae; Norway; antibiotics; epidemic; general practice; macrolide antibiotics; overprescription; prescribing

Mesh:

Substances:

Year:  2015        PMID: 25624311      PMCID: PMC4325451          DOI: 10.3399/bjgp15X683509

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  15 in total

1.  Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals.

Authors:  J Gnarpe; A Lundbäck; B Sundelöf; H Gnarpe
Journal:  Scand J Infect Dis       Date:  1992

2.  Single-run, parallel detection of DNA from three pneumonia-producing bacteria by real-time polymerase chain reaction.

Authors:  Reinhard B Raggam; Eva Leitner; Jörg Berg; Gerhard Mühlbauer; Egon Marth; Harald H Kessler
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

3.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

Authors:  J T Macfarlane; A Colville; A Guion; R M Macfarlane; D H Rose
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

4.  [Antibiotic use in Norway].

Authors:  Irene Litleskare; Hege Salvesen Blix; Marit Rønning
Journal:  Tidsskr Nor Laegeforen       Date:  2008-10-23

5.  Prescribing systemic antibiotics in general practice. A report from the Møre & Romsdal Prescription Study.

Authors:  J Straand; K S Rokstad; H Sandvik
Journal:  Scand J Prim Health Care       Date:  1998-06       Impact factor: 2.581

Review 6.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.

Authors:  Miyuki Morozumi; Takashi Takahashi; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2010-01-22       Impact factor: 2.211

Review 7.  [Community-acquired pneumonia in children].

Authors:  Dominique Gendrel; Florence Moulin
Journal:  Rev Prat       Date:  2007-11-15

8.  Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.

Authors:  A Meijer; C F Dagnelie; J C De Jong; A De Vries; T M Bestebroer; A M Van Loon; A I Bartelds; J M Ossewaarde
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

9.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

10.  The incidence and aetiology of respiratory tract infections in general practice--with emphasis on Mycoplasma pneumoniae.

Authors:  P A Mardh; B Hovelius; E Nordenfelt; R Rosenberg; L V Soltesz
Journal:  Infection       Date:  1976       Impact factor: 3.553

View more
  1 in total

1.  Assessing the potential of upper respiratory tract point-of-care testing: a systematic review of the prognostic significance of upper respiratory tract microbes.

Authors:  H V Thornton; K M E Turner; S Harrison; A Hammond; C Hawcroft; A D Hay
Journal:  Clin Microbiol Infect       Date:  2019-06-26       Impact factor: 8.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.